Cited by 2,485

The DOI matches its Crossref record.

A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

Donoghue, Mary, Hsieh, Frank, Baronas, Elizabeth, Godbout, Kevin, Gosselin, Michael, Stagliano, Nancy, Donovan, Michael, Woolf, Betty, Robison, Keith, Jeyaseelan, Raju, Breitbart, Roger E., Acton, Susan·2000·Circulation Research

Abstract

Abstract —ACE2, the first known human homologue of angiotensin-converting enzyme (ACE), was identified from 5′ sequencing of a human heart failure ventricle cDNA library. ACE2 has an apparent signal peptide, a single metalloprotease active site, and a transmembrane domain. The metalloprotease catalytic domains of ACE2 and ACE are 42% identical, and comparison of the genomic structures indicates that the two genes arose through duplication. In contrast to the more ubiquitous ACE, ACE2 transcripts are found only in heart, kidney, and testis of 23 human tissues examined. Immunohistochemistry shows ACE2 protein predominantly in the endothelium of coronary and intrarenal vessels and in renal tubular epithelium. Active ACE2 enzyme is secreted from transfected cells by cleavage N-terminal to the transmembrane domain. Recombinant ACE2 hydrolyzes the carboxy terminal leucine from angiotensin I to generate angiotensin 1-9, which is converted to smaller angiotensin peptides by ACE in vitro and by cardiomyocytes in culture. ACE2 can also cleave des-Arg bradykinin and neurotensin but not bradykinin or 15 other vasoactive and hormonal peptides tested. ACE2 is not inhibited by lisinopril or captopril. The organ- and cell-specific expression of ACE2 and its unique cleavage of key vasoactive peptides suggest an essential role for ACE2 in the local renin-angiotensin system of the heart and kidney. The full text of this article is available at http://www.circresaha.org.

Overview

Integrity signals

Registry

Crossref · 10.1161/01.res.87.5.e1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Acute stress‐induced hypertension is resolved by elevated expression of ACE2, a receptor used by SARS‐CoV‐2 for cellular entry.

    “Acute stress‐induced hypertension is resolved by elevated expression of angiotensin converting enzyme 2 (ACE2), a receptor used by SARS‐CoV‐2 for cellular entry (Donoghue et al., 2000; Hoffmann et al., 2020).”

    From On race, human variation, and who gets and dies of sepsis (2022) · cites this paper as Donoghue et al., 2000

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 24

  1. 10.1021/bi00243a012 · DOI
  2. 10.1016/S0021-9258(18)98626-6 · DOI
  3. 10.1159/000176938 · DOI
  4. 10.1016/0895-7061(95)00349-5 · DOI
  5. 10.1681/ASN.V991716 · DOI
  6. Higgins DG, Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci. 1989;5:151–153.
  7. 10.1091/mbc.2.12.1081 · DOI
  8. 10.1007/s003359900171 · DOI
  9. 10.1073/pnas.85.24.9386 · DOI
  10. 10.1016/S0162-3109(97)00032-5 · DOI
  11. 10.1073/pnas.95.1.138 · DOI
  12. Skeggs L Jr. Historical overview of the renin-angiotensin system. In: Doyle AE Bearn AG eds. Hypertension and the Angiotensin System: Therapeutic Approaches. New York NY: Raven Press; 1984:31–45.
  13. 10.1016/0196-9781(89)90133-2 · DOI
  14. 10.1016/0006-2952(90)90058-S · DOI
  15. 10.1152/ajpcell.1992.263.4.C851 · DOI
  16. 10.1016/0167-4838(86)90125-1 · DOI
  17. 10.1016/S0006-291X(86)80535-6 · DOI
  18. 10.1016/0006-291X(88)90257-4 · DOI · Paper page
  19. 10.1016/0162-3109(95)00011-H · DOI
  20. 10.1016/S0165-6147(99)01357-7 · DOI
  21. 10.1007/BF02222201 · DOI
  22. 10.1016/S0008-6363(99)00202-3 · DOI
  23. Lorell BH. Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease. Am J Cardiol. 1999;83:48H–52H.
  24. 10.1007/BF02071129 · DOI

Cited by

Sorted by citations

Metadata

Authors
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., Breitbart, R. E., & Acton, S.
Affiliations
From Millennium Pharmaceuticals, Inc, Cambridge, Mass. Current address for M.G. is Praecis Pharmaceuticals, Cambridge, Mass.
Venue
Circulation Research
Published
2000-09
Volume
87
Issue
5
ISSN
  • 0009-7330
  • 1524-4571
Cited by
2,485
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review